Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects
Men Over Age 75 Shouldn’t Be Screened For Prostate Cancer, Task Force Says
Quality Of Care Varies Widely For Prostate Cancer, Study Says
Prostatectomy Improves Outcome In Some Men
Risk of Relapse Continues After Five Years of Therapy
Two Breast Cancer Screening Methods Found Equivalent
Zometa Prevents Bone Loss In Premenopausal Women
Risk Assessment Key In Long-Term Treatment
Survey Finds Misconceptions About Cancer Worldwide
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Fifth time’s a charm? Mikaela Naylon Give Kids a Chance Act is included in FY26 spending bill
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
